Patent details

LUC50030 Product Name: epcoritamab

Basic Information

Publication number:
LUC50030
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP231741596
Legal Status:
Pending & Published
Application number:
LUC50030
First applicant's nationality:
Procedural language:
English

Marketing Authorization

Marketing Authorization Number:
EU/1/23/1759
Marketing Authorization Type:
Marketing Authorization Date:
25/09/2023
Marketing Authorization Status:
Accepted
Marketing Authorization Country:
Luxembourg (LU)

Dates

Filing date:
04/12/2025
First Marketing Authorization date:
25/09/2023
Grant date:
Activation date:
Publication date:
04/12/2025
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
25/09/2038
SPC Extension Expiration:
25/09/2038
Rejection date:
Withdrawal date:

Owner

From:
04/12/2025
 
 

Name:
Genmab A/S
Address:
Carl Jacobsens Vej 30, 2500 Valby, Denmark (DK)

Agent

Name:
Dennemeyer & Associates S.A.
From:
04/12/2025
Address:
55, rue des Bruyères, L-1274, HOWALD, Luxembourg (LU)
To:

Publication

Bulletin

Bulletin Heading:
SPC1
Bulletin edition number:
2026/01
Publication date:
05/01/2026
Description:
Section C : Published requests for Supplementary Protection Certificates – I1 publication

Annual Fees

Annual Fee Due Date:
31/01/2035
Annual Fee Number:
21
Annual Fee Amount:
410 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
04/12/2025 Outgoing Correspondence 3
04/12/2025 General Document 6
04/12/2025 General Document 5
04/12/2025 General Document 1
04/12/2025 General Document 3
04/12/2025 General Document 3
04/12/2025 General Document 96
04/12/2025 General Document 2
04/12/2025 General Document 1
04/12/2025 General Document 44
04/12/2025 Application Form 5
04/12/2025 Outgoing Correspondence 1
04/12/2025 Publication 1